Literature DB >> 12151695

Yoghurt biotherapy: contraindicated in immunosuppressed patients?

Gordon MacGregor1, A J Smith, B Thakker, J Kinsella.   

Abstract

A fatal case of Lactobacillus rhamnosus septicaemia after prolonged oral vancomycin for recalcitrant Clostridium difficile infection is reported. The patient was immunosuppressed with cyclophosphamide and steroids for Sjögren's syndrome. The administration of Lactobacillus spp as "biotherapy" may be hazardous in such circumstances.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12151695      PMCID： PMC1742399          DOI： 10.1136/pmj.78.920.366

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  11 in total

Review 1.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 2.  Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.

Authors:  Li Wen; Andrew Duffy
Journal:  J Nutr       Date:  2017-06-14       Impact factor: 4.798

3.  Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells.

Authors:  Shiuh-Bin Fang; Hsin-Yu Shih; Chih-Hung Huang; Li-Ting Li; Chia-Chun Chen; Hsu-Wei Fang
Journal:  Support Care Cancer       Date:  2014-02-06       Impact factor: 3.603

4.  Intraspecific genotypic characterization of Lactobacillus rhamnosus strains intended for probiotic use and isolates of human origin.

Authors:  M Vancanneyt; G Huys; K Lefebvre; V Vankerckhoven; H Goossens; J Swings
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

5.  Lactobacillus rhamnosus bacteremia: an emerging clinical entity.

Authors:  F Gouriet; M Million; M Henri; P-E Fournier; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-28       Impact factor: 3.267

6.  The Use of a Brochure to Enable CAM-with-Chemotherapy Patient Education.

Authors:  Peter J Smith; Alexandra M Clavarino; Jeremy E Long; Kathryn J Steadman
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

7.  Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.

Authors:  Wei-Syun Hu; Peramaiyan Rajendran; Bor-Show Tzang; Yu-Lan Yeh; Chia-Yao Shen; Ray-Jade Chen; Tsung-Jung Ho; Viswanadha Vijaya Padma; Yi-Hsing Chen; Chih-Yang Huang
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

Review 8.  Can Gut Microbiota Affect Dry Eye Syndrome?

Authors:  Jayoon Moon; Chang Ho Yoon; Se Hyun Choi; Mee Kum Kim
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 9.  Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options.

Authors:  Mattia Trunfio; Silvia Scabini; Walter Rugge; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  Microorganisms       Date:  2022-06-23

10.  Antioxidant Activity and Quality Characteristics of Yogurt Added Green Olive Powder during Storage.

Authors:  Won-Young Cho; Su-Jung Yeon; Go-Eun Hong; Ji-Han Kim; Chuluunbat Tsend-Ayush; Chi-Ho Lee
Journal:  Korean J Food Sci Anim Resour       Date:  2017-12-31       Impact factor: 2.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.